BMC Pediatrics

official impact factor 1.90

Open Access Research article

Quality of paediatric blood transfusions in two district hospitals in Tanzania: a cross-sectional hospital based study

Dominic Mosha1*, Anja Poulsen2,3, Hugh Reyburn2,4, Elimsaada Kituma1, Frank Mtei2 and Ib C Bygbjerg3

Author Affiliations

1 Kilimanjaro Christian Medical Centre (KCMC), PO Box 3010, Moshi, Tanzania

2 Joint Malaria Programme, PO Box 2228, Moshi, Tanzania

3 Department of International Health, Immunology & Microbiology, University of Copenhagen, 5 Įžster Farimagsgade Building 16, P.O. Box 2099, DK-1014 Copenhagen K, Denmark

4 Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK

For all author emails, please log on.

BMC Pediatrics 2009, 9:51 doi:10.1186/1471-2431-9-51

Published: 14 August 2009

Abstract

Background

Blood transfusion (BT) can be lifesaving for children; however, monitoring the quality of BT is important. The current study describes the quality of paediatric BT delivered in two district hospitals in north-east Tanzania in order to identify areas for quality assurance and improvement in the administration of BT.

Methods

All 166 children admitted in the paediatric wards and receiving BT through April to June 2007 were prospectively observed. Medical records, request forms and registers in the laboratories were reviewed to identify blood source, blood screening and indications for BT. BT was observation before, during and after transfusion process.

Results

Malaria related anaemia accounted for 98% of the BTs. Ninety-two percent of the children were assessed for paleness. Clinical signs such as difficult breathing and symptoms of cardiac failure were only assessed in 67% and 15% of the children respectively, prior to the BT decision. Pre-transfusion haemoglobin and body temperature were recorded in 2/3 of the patients, but respiratory rate and pulse rate were not routinely recorded. In 40% of BTs, the transfusion time exceeded the recommended 4 hours.

The zonal blood bank (ZBB) and local donors accounted for 10% and 90% of the blood, respectively. ABO and RhD typing and screening for HIV and syphilis were undertaken in all transfused blood. Evidence for hepatitis B or C infection was not checked except in the ZBB.

Conclusion

Criteria for BT are not always fulfilled; time to initiate and complete the transfusion is often unacceptable long and monitoring of vital signs during BT is poor. Blood from the ZBB was often not available and BT often depended on local donors which implied lack of screening for hepatitis B and C. It is recommended that an external supervision system be established to monitor and evaluate the quality of BT performance in the laboratories as well as in wards.